Kedaara, TA Associates vie for minority stake in Sagent Pharma
Kedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 ...
pharmaphorum11h
GSK ends decades-long hiatus in oral antibiotics for UTIs
The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary ...
Biomea Fusion, Inc.: Biomea Fusion Announces Leadership Transition
Board member Mick Hitchcock named interim CEO replacing Thomas Butler.COO and President Ramses Erdtmann continuing at Biomea in current role.REDWOOD CITY, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- ...
Interleukin-targeting biologics associated with lower infection rates in older psoriatic patients
Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...
C&EN7h
Antiviral unveiled that goes after multiple coronaviruses
This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.